Latest Midbrain Stories
SAN DIEGO, Oct. 19 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, announced today that enrollment has begun in a new double-blind sham surgery-controlled Phase 2b study evaluating CERE-120 in Parkinson's disease patients.
Rui Costa, Principal Investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de CiÃªncia (Portugal), and Xin Jin, of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (USA), describe in the latest issue of the journal Nature(*), that the activity of certain neurons in the brain can signal the initiation and termination of behavioural sequences we learn anew.
SAN DIEGO, April 28 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients.
In Germany alone, more than 300,000 people are afflicted by Parkinson's disease and the number is growing steadily.
Parkinsonâ€™s disease is caused by the degeneration of neurons in the midbrain. The mechanisms leading to the loss of these neurons, however, are largely unknown.
Parkinson's disease is caused by the degeneration of neurons in the midbrain. The mechanisms leading to the loss of these neurons, however, are largely unknown.
Dark cerebral matter fades in Parkinsonâ€™s disease, Investigation of the human brain discloses a distinct dark discoloration of the substantia nigra and locus coeruleus within parts of the brainstem. This is due to the bluish to brown-black pigment neuromelanin,
SAN DIEGO, Aug. 5 /PRNewswire/ -- Ceregene, Inc. today announced that the Michael J. Fox Foundation will provide partial funds for long-term follow-up testing of patients enrolled in the company's Phase 2 trial of CERE-120 for Parkinson's disease.
-- Longer term follow-up indicates modest efficacy in primary and related endpoints -- SAN DIEGO, May 27 /PRNewswire/ -- Ceregene, Inc. today reported additional clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease.
University of Texas at San Antonio scientists say they've found the phasic firing of dopamine neurons is key to the brain's prediction of rewards. The researchers say their finding brings science a step closer to understanding the neurobiology that allows people to successfully learn motivated behaviors by associating environmental cues with rewarding outcomes. Assistant Professor Carlos Paladini and graduate student Collin Lobb collaborated with researchers at the University of Washington to...
The midbrain, also known as the mesencephalon is the part of the brain most responsible for vision, motor control, arousal, temperature regulation, alertness and hearing. Formation and Orientation The midbrain is found under the cerebral cortex and above the hindbrain. The mesencephalon is not divided into any other portions of the brain unlike the other two vesicles that stem from the neural tube. There are four separate lobes on the side of the cerebral aqueduct within the...